The intersection between immunotherapy and laser interstitial thermal therapy: a multipronged future of neuro-oncology. (15th July 2020)

• Record Type: Journal Article
• Authors: Srinivasan, Ethan S.; Sankey, Eric W.; Grabowski, Matthew M.; Chongsathidkiet, Pakawat; Fecci, Peter E.
• Is Part Of: International journal of hyperthermia. Volume 37:Number 2(2020)
• Page Start: 27
• Page End: 34
• Publication Date: 2020-07-15
• Subjects: Laser interstitial thermal therapy (LITT) -- hyperthermia -- immunotherapy -- cancer -- neurosurgery -- neuro-oncology; Thermotherapy -- Periodicals; 615.832
• DOI: 10.1080/02656736.2020.1746413
• Languages: English
• ISSNs: 0265-6736

Abstract

Abstract: The rise of immunotherapy (IT) in oncological treatment has greatly improved outcomes in a number of disease states. However, its use in tumors of the central nervous system (CNS) remains limited for multiple reasons related to the unique immunologic tumor microenvironment. As such, it is valuable to consider the intersection of IT with additional treatment methods that may improve access to the CNS and effectiveness of existing IT modalities. One such combination is the pairing of IT with localized hyperthermia (HT) generated through technologies such as laser interstitial thermal therapy (LITT). The wide-ranging immunomodulatory effects of localized and whole-body HT have been investigated for some time. Hyperthermia has demonstrated immunostimulatory effects at the level of tumor cells, immune cells, and the broader environment governing potential immune surveillance. A thorough understanding of these effects as well as the current and upcoming investigations of such in combination with IT is important in considering the future directions of neuro-oncology.